Washington Dc, DCNCT01206920Now EnrollingIRB Ready

HIV Clinical Trial in Washington Dc, DC

Access cutting-edge hiv treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.

Sponsored by George Washington University

Quick Self-Assessment

See if you qualify for this Washington Dc location

Preparing your pre-screening questions…

Expert Care in Washington Dc

Access hiv specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hiv treatment provided free

Apply for This Washington Dc Location

Check if you qualify for this hiv clinical trial in Washington Dc, DC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Washington Dc

    Convenient for DC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Washington Dc site if eligible
  4. 4Begin participation

About This HIV Study in Washington Dc

The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and receiving care in Washington, DC.

Sponsor: George Washington University

Who Can Participate

Inclusion Criteria

Patient is receiving care for HIV at one or more of the twelve participating clinics in the DC Cohort.
Patient is either age 18 years or older, or seeks HIV care independently and is able to understand and sign informed consent.
Patient is a minor who is consented by a parent or legal guardian. Treatment Cohort

Exclusion Criteria

Patient is unable or refuses to provide informed consent.
Minor children ages 12 through 17 who are unaware of their HIV status Prevention Cohort Inclusion Criteria: Persons receiving any antiretroviral prescription without evidence of HIV or Hepatitis B infection
PrEP (e.g., TDF/FTC, Descovy, Apretude)
Combination ART indicative of nPEP in an HIV-uninfected person
Persons receiving an antiretroviral prescription indicative of DoxyPEP Doxycycline 200mg PO taken within 72 hrs of unprotected sexual encounter (or variations thereof where clearly not prescribed as a treatment course)
Test positive for ≥1 bacterial STI (positive gonorrhea (GC/NG) or chlamydia (CT) test or positive syphilis test requiring treatment within one year)
2 bacterial STI (GC, chlamydia, syphilis) tests at 2 or more different encounters
2 HIV tests at 2 or more different encounters
Patient requesting PrEP at their clinical visit
Patient requesting nPEP at their clinical visit
People who identify as injecting drugs Patients with a Z29.81 Encounter for HIV pre-exposure prophylaxis

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Washington Dc?

Yes, this clinical trial (NCT01206920) has an active research site in Washington Dc, DC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

HIV Treatment Options in Washington Dc, DC

If you're searching for hiv treatment options in Washington Dc, DC, this clinical trial (NCT01206920) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hiv clinical trials near you to find additional studies recruiting in your area.

More HIV AIDS Trials in Washington Dc, DC

See all hiv aids clinical trials recruiting in Washington Dc — not just this study.

Browse HIV AIDS Trials in Washington Dc →

Browse More Trials by Condition

HIV AIDS TrialsChronic Urticaria TrialsUrticaria TrialsAll Conditions →

Ready to Join in Washington Dc?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Washington Dc, DC